½ÃÀ庸°í¼­
»óǰÄÚµå
1392016

¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Radioactive Tracer Market, By Type, By Application, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀå ±Ô¸ð´Â 2023³â 32¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2030³â¿¡´Â 52¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2022³â 2023³â ½ÃÀå ±Ô¸ð 32¾ï 4,000¸¸ ´Þ·¯
¾÷Àû µ¥ÀÌÅÍ 2018-2021³â ¿¹Ãø ±â°£ 2023³â-2030³â
¿¹Ãø ±â°£ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.20% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 52¾ï 6,000¸¸ ´Þ·¯
±×¸² 1. ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2023³â
Radioactive Tracer Market-IMG1

¹æ»ç¼º Æ®·¹À̼­´Â ÀÇ·á, ¿¬±¸, ¼®À¯ Ž»ç µî ´Ù¾çÇÑ »ê¾÷¿¡¼­ ÇʼöÀûÀÎ µµ±¸°¡ µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·¹À̼­´Â ¹æ»ç¼±À» ¹æÃâÇÏ´Â ¹æ»ç¼º ¹°Áú·Î ±¸¼ºµÇ¾î ÀÖ¾î ½±°Ô °ËÃâ ¹× ÃøÁ¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̵éÀº ƯÁ¤ ºÐÀÚÀÇ ¿òÁ÷ÀÓÀ» ÃßÀûÇϰí, ´Ù¾çÇÑ »ý¹°ÇÐÀû °úÁ¤À» ¿¬±¸Çϰí, ÁöÇÏ ¸ÅÀå·®ÀÇ ÀáÀçÀûÀÎ °ø±Þ¿øÀ» È®ÀÎÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀåÀº ÀÇ·á Áø´Ü ¹× Ä¡·á, ȯ°æ ºÐ¾ß ¹× ¼®À¯È­ÇÐ ºÐ¾ß¿¡¼­ ¹æ»ç¼º Æ®·¹À̼­ÀÇ ¿ëµµ È®´ë·Î ÃÖ±Ù ¸î ³â°£ ÇöÀúÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú Áøº¸, ¸¸¼º Áúȯ Áõ°¡, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ´Ù¾çÇÑ ÁúȯÀ̳ª »óŸ¦ °ËÃâ ¹× ºÐ¼®Çϱâ À§ÇØ ¹æ»ç¼º Æ®·¹À̼­¸¦ ÀÌ¿ëÇÏ´Â ¾çÀüÀÚ¹æ»ç´ÜÃþÃÔ¿µ¹ý(PET)À̳ª ´Ü±¤ÀÚ¹æ»ç´ÜÃþÃÔ¿µ¹ý(SPECT) µîÀÇ ¿µ»ó Áø´Ü ±â¼úÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶§¹®¿¡ ÇöÀúÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ¹æ»ç¼º ¹°ÁúÀÇ »ç¿ë°ú Æó±â¿¡ °üÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ µîÀÇ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦±â°üÀº ¹æ»ç¼º Æ®·¹À̼­ÀÇ ¾ÈÀüÇÑ Ãë±Þ°ú Æó±â¸¦ º¸ÀåÇϱâ À§ÇØ ¾ö°ÝÇÑ ÁöħÀ» ºÎ°úÇϰí, ÀÌ·Î ÀÎÇØ Á¦Á¶ ºñ¿ëÀÌ Å©°Ô »ó½ÂÇÏ°í ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¼÷·ÃµÈ Àü¹®°¡ÀÇ °¡¿ë¼ºÀÌ Á¦Çѵǰí ÇÙÀÇÇÐ Ä¡·á¿Í °ü·ÃµÈ ºñ¿ëÀÌ ³ô´Ù´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ·¯ÇÑ °úÁ¦¿¡µµ ºÒ±¸ÇÏ°í ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀåÀº ¼ºÀå ±âȸ·Î °¡µæÇÕ´Ï´Ù. ¹æ»ç¼ºÀǾàǰÁ¦Á¶±â¼úÀÇ ½ÅÈï±¹ ½ÃÀåÀÇ ¹ßÀü°ú »õ·Î¿î ¹æ»ç¼ºµ¿À§¿ø¼Ò ½ÃÀ尳ôÀº ½ÃÀå°ü°èÀÚ¿¡°Ô »õ·Î¿î ±âȸ¸¦ °¡Á®¿Ã °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¼®À¯ ¹× °¡½º Ž»ç, ȯ°æ ¸ð´ÏÅ͸µ, »ê¾÷ °Ë»ç µîÀÇ »ê¾÷¿¡¼­ ¹æ»ç¼º Æ®·¹À̼­ÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 3¿ù 16ÀÏ Á¦¾à»ç Telix Pharmaceuticals Limited.´Â ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÌ 177Lu 177 PSMA Áö½Ã¿ä¹ýÀÌ ÀûÀÀµÇ´Â ÀüÀ̼º Àü¸³¼±¾Ï ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ Illuccix(°¥·ý Ga 68 °íÁ¦Å䯼µå ÁÖ»ç¾× Áغñ¿ë ŰƮ) Ãß°¡ ½Å¾à ½ÂÀÎ ½Åû(sNDA)À» ½ÂÀÎÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø±â°£(2023³â-2030³â) ½ÃÀå ±Ô¸ð¿Í º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» Á¦°øÇÕ´Ï´Ù.
  • ¶ÇÇÑ ¼­·Î ´Ù¸¥ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ Çà·ÄÀ» ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ ÁÖ¿ä °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ¿£ÅÍÇÁ¶óÀÌÁî ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­¸¦ ÅëÇØ ÀλçÀÌÆ®Àº ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀÌ ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯Çü ¾÷±×·¹À̵å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù.
  • ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ Áö¿øÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚ´Â ¼¼°è ¹æ»ç¼º ÃßÀû±â ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç °áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¸¸¼ºÁúȯÀÇ ÀÌȯÀ² Áõ°¡
    • ¹æ»ç¼º ÀǾàǰÀÇ ¹Ý°¨±â´Â ªÀº
    • Á¾¾çÇп¡ À־ÀÇ »õ·Î¿î ÀÀ¿ë
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã/½ÂÀÎ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ÇÕº´°ú Àμö ½Ã³ª¸®¿À

Á¦4Àå ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀå - Äڷγª ¹ÙÀÌ·¯½º(COVID-19) À¯ÇàÀÇ ¿µÇâ

  • ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃø ºÐ¼®
  • °æÁ¦Àû ¿µÇâ

Á¦5Àå ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀå : À¯Çüº°(2023³â-2030³â)

  • ¼Ò°³
  • Áø´Ü¿ë ¹æ»ç¼º Æ®·¹À̼­
  • Ä¡·á¿ë ¹æ»ç¼º Æ®·¹À̼­
  • ±âŸ

Á¦6Àå ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀå : ¿ëµµº°(2023³â-2030³â)

  • ¼Ò°³
  • Á¾¾çÇÐ
  • ½ÉÀ庴ÇÐ
  • ½Å°æ³»°ú
  • °©»ó¼±
  • Á¤Çü¿Ü°ú
  • ³»ºÐºñÇÐ
  • ±âŸ

Á¦7Àå ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2023³â-2030³â)

  • ¼Ò°³
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • Áø´Ü¼¾ÅÍ
  • Çмú¿¬±¸±â°ü
  • ±âŸ
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, Àü³â´ëºñ ¼ºÀå·ü(2018³â-2030³â)

Á¦8Àå ¼¼°è ¹æ»ç¼º Æ®·¹À̼­ ½ÃÀå : Áö¿ªº°(2023³â-2030³â)

  • ¼Ò°³
  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • µ¶ÀÏ
  • ¿µ±¹
  • ½ºÆäÀÎ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • È£ÁÖ
  • Çѱ¹
  • ASEAN ±¹°¡
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¾Æ¸£ÇîÆ¼³ª
  • ¸ß½ÃÄÚ
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
  • GCC ±¹°¡
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • PerkinElmer Inc.
  • Cardinal Health
  • Bracco
  • NTP Radioisotopes
  • Nordion(Canada) Inc.
  • Curium
  • IRE
  • Telix Pharmaceuticals Limited
  • NorthStar Medical Radioisotopes, LLC
  • Lantheus Holdings, Inc.
  • Eckert & Ziegler
  • Siemens Healthineers
  • GE Healthcare
  • Mallinckrodt Nuclear Medicine LLC
  • Jubilant DraxImage Inc.
  • Sumitomo Heavy Industries, Ltd.

Á¦10Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
BJH 23.12.21

Global radioactive tracer market size is expected to reach US$ 5.26 Bn by 2030, from US$ 3.24 Bn in 2023, exhibiting a CAGR of 7.2% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 3.24 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 7.20% 2030 Value Projection: US$ 5.26 Bn
Figure 1. Global Radioactive Tracer Market Share (%), By Region, 2023
Radioactive Tracer Market - IMG1

Radioactive tracers have become an essential tool in several industries including healthcare, research, and oil exploration. These tracers consist of radioactive substances that emit radiation, which can be easily detected and measured. These are used to track the movement of specific molecules, study various biological processes, and identify potential sources of underground reserves. The global radioactive tracer market has witnessed significant growth in recent years, owing to increasing applications of radioactive tracers in medical diagnostics and treatment, and in the environmental and petrochemical sectors.

Market Dynamics:

Global radioactive tracer market growth is driven by several factors including technological advancements, increasing prevalence of chronic diseases, and growing demand for personalized medicine. The market is witnessing significant growth due to rising adoption of diagnostic imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) that utilize radioactive tracers to detect and analyze various diseases and conditions.

The market faces certain challenges such as stringent regulations related to the use and disposal of radioactive substances. Regulatory bodies impose strict guidelines to ensure the safe handling and disposal of radioactive tracers, wand this significantly increases the cost of production and affects the market growth. The limited availability of skilled professionals and the high cost associated with nuclear medicine procedures are expected to restrain the market growth.

Despite these challenges, global radioactive tracer market is filled with opportunities for growth. Advancements in radiopharmaceutical manufacturing techniques and the development of new radioactive isotopes are expected to create new opportunities for market players. Moreover, increasing adoption of radioactive tracers in industries such as oil and gas exploration, environmental monitoring, and industrial testing is expected to drive the market growth further.

For instance, on March 16, 2023, Telix Pharmaceuticals Limited., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved a supplementary New Drug Application (sNDA) for Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection) to enable patients with metastatic prostate cancer, for whom 177Lu 177 PSMA-directed therapy is indicated.

Key features of the study:

  • This report provides in-depth analysis of the global radioactive tracer market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global radioactive tracer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include PerkinElmer Inc., Cardinal Health, Bracco, NTP Radioisotopes, Nordion (Canada) Inc., Curium, IRE, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes, LLC, Lantheus Holdings, Inc., Eckert & Ziegler, Siemens Healthineers, GE Healthcare, Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., and Sumitomo Heavy Industries, Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global radioactive tracer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radioactive tracer market

Detailed Segmentation:

  • By Type
    • Diagnostic Radioactive Tracers
    • Therapeutic Radioactive Tracers
    • Others
  • By Application
    • Oncology
    • Cardiology
    • Neurology
    • Thyroid
    • Orthopedic
    • Endocrinology
    • Others
  • By End User
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • Academic & Research Institutes
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top companies in Global Radioactive Tracer Market:
    • PerkinElmer Inc.
    • Cardinal Health
    • Bracco
    • NTP Radioisotopes
    • Nordion (Canada) Inc.
    • Curium
    • IRE
    • Telix Pharmaceuticals Limited
    • NorthStar Medical Radioisotopes, LLC
    • Lantheus Holdings, Inc.
    • Eckert & Ziegler
    • Siemens Healthineers
    • GE Healthcare
    • Mallinckrodt Nuclear Medicine LLC
    • Jubilant DraxImage Inc.
    • Sumitomo Heavy Industries, Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Radioactive Tracer, By Type
    • Market Radioactive Tracer, By Application
    • Market Radioactive Tracer, By End User
    • Market Radioactive Tracer, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of chronic diseases
    • Short half-life of radiopharmaceuticals
    • Emerging applications in oncology
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Radioactive Tracer Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Radioactive Tracer Market, By Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Diagnostic Radioactive Tracers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Therapeutic Radioactive Tracers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Radioactive Tracer Market, By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Thyroid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Radioactive Tracer Market, By End User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Radioactive Tracer Market, By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,( US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardinal Health
  • Bracco
  • NTP Radioisotopes
  • Nordion (Canada) Inc.
  • Curium
  • IRE
  • Telix Pharmaceuticals Limited
  • NorthStar Medical Radioisotopes, LLC
  • Lantheus Holdings, Inc.
  • Eckert & Ziegler
  • Siemens Healthineers
  • GE Healthcare
  • Mallinckrodt Nuclear Medicine LLC
  • Jubilant DraxImage Inc.
  • Sumitomo Heavy Industries, Ltd.
  • Analyst Views

10. Section

  • Research Methodology
  • About us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦